These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33835497)

  • 1. Buprenorphine may be effective for treatment of paramyotonia congenita.
    Ravaglia S; Maggi L; Zito A; Arceri S; Gallotti P; Altamura C; Desaphy JF; Bernasconi P; Alfonsi E
    Muscle Nerve; 2021 Jul; 64(1):95-99. PubMed ID: 33835497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.
    Ke Q; Ye J; Tang S; Wang J; Luo B; Ji F; Zhang X; Yu Y; Cheng X; Li Y
    J Physiol; 2017 Nov; 595(22):6837-6850. PubMed ID: 28940424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label trial of ranolazine for the treatment of paramyotonia congenita.
    Lorusso S; Kline D; Bartlett A; Freimer M; Agriesti J; Hawash AA; Rich MM; Kissel JT; David Arnold W
    Muscle Nerve; 2019 Feb; 59(2):240-243. PubMed ID: 30390395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.
    Tan SV; Matthews E; Barber M; Burge JA; Rajakulendran S; Fialho D; Sud R; Haworth A; Koltzenburg M; Hanna MG
    Ann Neurol; 2011 Feb; 69(2):328-40. PubMed ID: 21387378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.
    Trivedi JR; Bundy B; Statland J; Salajegheh M; Rayan DR; Venance SL; Wang Y; Fialho D; Matthews E; Cleland J; Gorham N; Herbelin L; Cannon S; Amato A; Griggs RC; Hanna MG; Barohn RJ;
    Brain; 2013 Jul; 136(Pt 7):2189-200. PubMed ID: 23771340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of repetitive nerve stimulation, exercise, and cold in differentiating myotonic disorders.
    Michel P; Sternberg D; Jeannet PY; Dunand M; Thonney F; Kress W; Fontaine B; Fournier E; Kuntzer T
    Muscle Nerve; 2007 Nov; 36(5):643-50. PubMed ID: 17654559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of paramyotonia congenita without periodic paralysis: electrophysiological and molecular genetic studies.
    Park JH; Lee YW; Park SA; Lee TK; Rho HJ; Sung KB
    Neurologist; 2010 May; 16(3):203-5. PubMed ID: 20445432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A zebrafish model of nondystrophic myotonia with sodium channelopathy.
    Nam TS; Zhang J; Chandrasekaran G; Jeong IY; Li W; Lee SH; Kang KW; Maeng JS; Kang H; Shin HY; Park HC; Kim S; Choi SY; Kim MK
    Neurosci Lett; 2020 Jan; 714():134579. PubMed ID: 31669315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy.
    Mankodi A; Grunseich C; Skov M; Cook L; Aue G; Purev E; Bakar D; Lehky T; Jurkat-Rott K; Pedersen TH; Childs RW
    Neuromuscul Disord; 2015 Nov; 25(11):908-12. PubMed ID: 26494408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged attacks of weakness with hypokalemia in SCN4A-related paramyotonia congenita.
    van Osch T; Stunnenberg BC; Sternberg D; Kerklaan BJ
    Muscle Nerve; 2018 Oct; 58(4):E27-E28. PubMed ID: 30028520
    [No Abstract]   [Full Text] [Related]  

  • 11. Paramyotonia congenita: from clinical diagnosis to in silico protein modeling analysis.
    Nurputra DK; Nakagawa T; Takeshima Y; Harahap IS; Morikawa S; Sakaeda T; Lai PS; Matsuo M; Takaoka Y; Nishio H
    Pediatr Int; 2012 Oct; 54(5):602-12. PubMed ID: 22507243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eulenburg's paramyotonia congenita].
    Sallansonnet-Froment M; Bounolleau P; De Greslan T; Ricard D; Taillia H; Renard JL
    Rev Neurol (Paris); 2007 Nov; 163(11):1083-90. PubMed ID: 18033047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines on clinical presentation and management of nondystrophic myotonias.
    Stunnenberg BC; LoRusso S; Arnold WD; Barohn RJ; Cannon SC; Fontaine B; Griggs RC; Hanna MG; Matthews E; Meola G; Sansone VA; Trivedi JR; van Engelen BGM; Vicart S; Statland JM
    Muscle Nerve; 2020 Oct; 62(4):430-444. PubMed ID: 32270509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.
    Farinato A; Altamura C; Imbrici P; Maggi L; Bernasconi P; Mantegazza R; Pasquali L; Siciliano G; Lo Monaco M; Vial C; Sternberg D; Carratù MR; Conte D; Desaphy JF
    Pharmacol Res; 2019 Mar; 141():224-235. PubMed ID: 30611854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Korean family with Arg1448Cys mutation of SCN4A channel causing paramyotonia congenita: electrophysiologic, histopathologic, and molecular genetic studies.
    Kim DS; Kim EJ; Jung DS; Park KH; Kim IJ; Kwak KY; Kim CM; Ko HY
    J Korean Med Sci; 2002 Dec; 17(6):856-60. PubMed ID: 12483017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A SCN4A mutation causing paramyotonia congenita.
    Palma C; Prior C; Gómez-González C; Rodríguez-Antolin C; Martínez-Montero P; Pérez de Ayala L; Pascual SI; Molano Mateos J
    Neuromuscul Disord; 2017 Dec; 27(12):1123-1125. PubMed ID: 29111379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, electrophysiological and genetic features of a large Australian family with paramyotonia congenita.
    Parasivam S; Krupa M; Slee M; Thyagarajan DE
    Med J Aust; 2009 Mar; 190(6):334-6. PubMed ID: 19296818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paramyotonia Congenita with Persistent Distal and Facial Muscle Weakness: A Case Report with Literature Review.
    Taminato T; Mori-Yoshimura M; Miki J; Sasaki R; Sato N; Oya Y; Nishino I; Takahashi Y
    J Neuromuscul Dis; 2020; 7(2):193-201. PubMed ID: 32083589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relief from episodic weakness with pyridostigmine in paramyotonia congenita: a family study.
    Khadilkar SV; Singh RK; Mansukhani KA; Urtizberea JA; Sternberg D
    Muscle Nerve; 2010 Jan; 41(1):133-7. PubMed ID: 19768756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.